EOFLOW Co.,Ltd. (KOSDAQ:294090)
South Korea
· Delayed Price · Currency is KRW 1,490.00
-89.00 (-5.64%)
Mar 21, 2025, 5:10 PM KST
-54.92% (1Y)
| Market Cap | 51.11B |
| Revenue (ttm) | 5.03B |
| Net Income (ttm) | -62.62B |
| Shares Out | 34.30M |
| EPS (ttm) | -2,058.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 857,110 |
| Average Volume | n/a |
| Open | 1,535.00 |
| Previous Close | 1,579.00 |
| Day's Range | 1,455.00 - 1,570.00 |
| 52-Week Range | 1,455.00 - 18,500.00 |
| Beta | 0.28 |
| RSI | 24.84 |
| Earnings Date | May 13, 2025 |
About EOFLOW
EOFLOW Co.,Ltd. develops and provides drug delivery solutions. The company offers EOPatch, a wearable insulin pump system. EOFLOW Co.,Ltd. was founded in 2011 and is based in Seongnam, South Korea. [Read more]
Industry Medical Devices
Sector Healthcare
Founded 2011
Employees 106
Stock Exchange KOSDAQ
Ticker Symbol 294090
Financial Performance
In 2024, EOFLOW's revenue was 5.03 billion, a decrease of -23.65% compared to the previous year's 6.59 billion. Losses were -62.62 billion, 1.10% more than in 2023.
Financial StatementsNews
Insulet awarded $452M in damages in EOFlow case
Insulet (PODD) wins $452M in trade secrets case against EOFlow Co., awarded $170M compensatory and $282M exemplary damages.
4 months ago - Seeking Alpha